Source: https://patents.com/us-7941213.html
Timestamp: 2019-10-20 18:52:18
Document Index: 15224229

Matched Legal Cases: ['art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42']

US Patent # 7,941,213. System and method to evaluate electrode position and spacing - Patents.com
United States Patent 7,941,213
Markowitz , et al. May 10, 2011
Inventors: Markowitz; H. Toby (Roseville, MN), Falkner; Phillip (Minneapolis, MN), Hettrick; Douglas A. (Andover, MN), Sowelam; Sameh (Fridley, MN)
Appl. No.: 12/183,796
11966382 Dec., 2007
60912610 Apr., 2007
60882420 Dec., 2006
60882431 Dec., 2006
60882435 Dec., 2006
60882428 Dec., 2006
60882430 Dec., 2006
60882425 Dec., 2006
Current U.S. Class: 607/2
Field of Search: 607/2,27,11,36,4,44,9,45 600/508,509 606/1
4696304 September 1987 Chin
5035246 July 1991 Heuvelmans et al.
5167239 December 1992 Cohen et al.
5265622 November 1993 Barbere
5512920 April 1996 Gibson
5639276 June 1997 Weinstock et al.
5840025 November 1998 Ben-Haim
6088527 July 2000 Rybczynski
6256121 July 2001 Lizotte et al.
6330356 December 2001 Sundareswaran et al.
6389187 May 2002 Greenaway et al.
6470205 October 2002 Bosselmann et al.
6546270 April 2003 Goldin et al.
6569160 May 2003 Goldin et al.
6574498 June 2003 Gilboa
6595989 July 2003 Schaer
6868195 March 2005 Fujita et al.
6888623 May 2005 Clements
6892091 May 2005 Ben-Haim et al.
7020522 March 2006 Hoijer et al.
7047073 May 2006 Hoijer et al.
7189208 March 2007 Beatty et al.
7207989 April 2007 Pike, Jr. et al.
7215430 May 2007 Kacyra et al.
7263397 August 2007 Hauck et al.
7305121 December 2007 Kaufmann et al.
7421300 September 2008 Smits et al.
7479141 January 2009 Kleen et al.
2001/0031920 October 2001 Kaufman et al.
2002/0045810 April 2002 Ben-Haim
2002/0049375 April 2002 Strommer et al.
2003/0028118 February 2003 Dupree et al.
2003/0055324 March 2003 Wasserman
2003/0078494 April 2003 Panescu et al.
2003/0108853 June 2003 Chosack et al.
2003/0225434 December 2003 Glantz et al.
2004/0001075 January 2004 Balakrishnan et al.
2004/0064159 April 2004 Hoijer et al.
2004/0070582 April 2004 Smith et al.
2004/0097805 May 2004 Verard et al.
2004/0162599 August 2004 Kurth
2004/0215298 October 2004 Richardson et al.
2004/0249281 December 2004 Olstad
2004/0254437 December 2004 Hauck et al.
2005/0119550 June 2005 Serra et al.
2005/0187432 August 2005 Hale et al.
2005/0245803 November 2005 Glenn, Jr. et al.
2006/0013523 January 2006 Childlers et al.
2006/0058604 March 2006 Avinash et al.
2006/0153468 July 2006 Solf et al.
2006/0173268 August 2006 Mullick et al.
2006/0229513 October 2006 Wakai
2006/0247520 November 2006 McGee
2007/0016084 January 2007 Denault
2007/0043413 February 2007 Eversull et al.
2007/0046661 March 2007 Ma et al.
2007/0135803 June 2007 Belson
2007/0156019 July 2007 Larkin et al.
2007/0167801 July 2007 Webler et al.
2007/0270682 November 2007 Huang et al.
2007/0299351 December 2007 Harlev et al.
2007/0299352 December 2007 Harlev et al.
2008/0024493 January 2008 Bordoloi et al.
2008/0038197 February 2008 John et al.
2008/0071142 March 2008 Gattani et al.
2008/0118117 May 2008 Gauldie et al.
2008/0183072 July 2008 Robertson et al.
2008/0207997 August 2008 Higgins et al.
2008/0243025 October 2008 Holmstrom et al.
2009/0017430 January 2009 Muller-Daniels et al.
2009/0063118 March 2009 Dachille et al.
2009/0103793 April 2009 Borland et al.
2009/0126575 May 2009 Son et al.
2009/0129477 May 2009 Yang
2009/0192381 July 2009 Brockway et al.
2009/0253976 October 2009 Harlev et al.
2009/0262109 October 2009 Markowitz et al.
2009/0262979 October 2009 Markowitz et al.
2009/0262980 October 2009 Markowitz et al.
2009/0262982 October 2009 Markowitz et al.
2009/0262992 October 2009 Markowitz et al.
2009/0264727 October 2009 Markowitz et al.
2009/0264738 October 2009 Markowitz et al.
2009/0264739 October 2009 Markowitz et al.
2009/0264740 October 2009 Markowitz et al.
2009/0264741 October 2009 Markowitz et al.
2009/0264742 October 2009 Markowitz et al.
2009/0264743 October 2009 Markowitz et al.
2009/0264744 October 2009 Markowitz et al.
2009/0264745 October 2009 Markowitz et al.
2009/0264746 October 2009 Markowitz et al.
2009/0264747 October 2009 Markowitz et al.
2009/0264748 October 2009 Markowitz et al.
2009/0264749 October 2009 Markowitz et al.
2009/0264750 October 2009 Markowitz et al.
2009/0264751 October 2009 Markowitz et al.
2009/0264752 October 2009 Markowitz et al.
2009/0264777 October 2009 Markowitz et al.
2009/0265128 October 2009 Markowitz et al.
2009/0267773 October 2009 Markowitz et al.
2009/0297001 December 2009 Markowitz et al.
2010/0152571 June 2010 Hartmann et al.
363117 Apr., 1990 EP
1393674 Mar., 2004 EP
1421913 May., 2004 EP
WO-02064040 Aug., 2002 WO
WO-2005112836 Dec., 2005 WO
WO-2006042039 Apr., 2006 WO
WO-2006117773 Nov., 2006 WO
WO-2007067945 Jun., 2007 WO
WO-2007111542 Oct., 2007 WO
WO-2007136451 Nov., 2007 WO
WO-2008147961 Dec., 2008 WO
"EnSite NavX.TM. Navigation & Visualization Technology." 3 pages, St. Jude Medical. http://www.sjmprofessional.com/Products/US/Mapping-and-Visualiza- tion/EnSite-NavX-Navigation-and-Visualization-Technology.aspx Web. Accessed Jun. 19, 2009. cited by other .
"Local Lisa.RTM. Intracardiac Navigation System Model 9670000/9670025." Technical Manual Version 1.2, Chapter 1, pp. 1-19. 2004. cited by other .
Brenner, David J., Ph.D., "Computed Tomography--An Increasing Source of Radiation Exposure", The New England Journal of Medicine (Nov. 29, 2007), pp. 2277-2284. cited by other .
Gepstein, Lior, M.D., "A Novel Method for Nonfluoroscopic Catheter-Based Electroanatomical Mapping of the Heart, In Vitro and In Vivo Accuracy Results", American Heart Association, Learn and Live, Circulation (1997), http://circ.ahajournals.org/cgi/content/abstract/95/6/1611 printed Oct. 2, 2008. cited by other .
International Preliminary Report on Patentability and Written Opinion for PCT/US2009/040998 mailed Oct. 28, 2010, 2009 claiming benefit of U.S. Appl. No. 12/421,332, filed Apr. 9, 2009; which claims priority to U.S. Appl. No. 61/105,957, filed Oct. 16, 2008; U.S. Appl. No. 12/117,549, filed May 8, 2008. cited by other .
International Preliminary Report on Patentability and Written Opinion for PCT/US2009/0400984 mailed Oct. 28, 2010, claiming benefit of U.S. Appl. No. 12/117,549, filed May 8, 2008. cited by other .
International Preliminary Report on Patentability and Written Opinion for PCT/US2009/040979 mailed Oct. 28, 2010 claiming benefit of U.S. Appl. No. 12/117,537, filed May 8, 2008. cited by other .
International Search Report and Written Opinion for PCT/US2008/088189 mailed Apr. 3, 2009, claiming benefit of U.S. Appl. No. 12/183,796, filed Jul. 31, 2008; and claims priority to U.S. Appl. No. 11/966,382, filed Dec. 28, 2007. cited by other .
International Search Report and Written Opinion for PCT/US2009/0400984 mailed Sep. 21, 2009, claiming benefit of U.S. Appl. No. 12/117,549, filed May 8, 2008. cited by other .
International Search Report and Written Opinion for PCT/US2009/040998 mailed Jul. 29, 2009 claiming benefit of U.S. Appl. No. 12/421,332, filed Apr. 9, 2009; which claims priority to U.S. Appl. No. 61/105,957, filed Oct. 16, 2008; U.S. Appl. No. 12/117,549, filed May 8, 2008. cited by other .
International Search Report and Written Opinion for PCT/US2009/067486 mailed May 4, 2010, claiming benefit of U.S. Appl. No. 12/336,085, filed Dec. 16, 2008. cited by other .
International Search Report and Written Opinon for PCT/US2009/040979 mailed Sep. 21, 2009 claiming benefit of U.S. Appl. No. 12/117,537, filed May 8, 2008. cited by other .
Invitation to Pay Additional Fees for PCT/US2009/0400984 mailed Jul. 30, 2009, claiming benefit of U.S. Appl. No. 12/117,549, filed May 8, 2008. cited by other .
Invitation to Pay Additional Fees for PCT/US2009/040979 mailed Jul. 30, 2009 claiming benefit of U.S. Appl. No. 12/117,537, filed May 8, 2008. cited by other .
Invitation to Pay Additional Fees for PCT/US2009/067486 mailed Mar. 5, 2010, claiming benefit of U.S. Appl. No. 12/336,085, filed Dec. 16, 2008. cited by other .
Invitation to Pay Additional Fees mailed Jul. 7, 2010 for PCT/US2010/030534 claiming benefit of U.S. Appl. No. 12/421,375, filed Apr. 9, 2009. cited by other .
Jiang, Yuan. "An Impedance-Based Catheter Poisitioning System for Cardiac Mapping and Navigation." IEEE Transactions on Biomedical Engineering, (Aug. 2009) pp. 1963-1970, vol. 56, No. 8. cited by other .
Markowitz, Toby, et al., "Unleaded: The Fluoroless 3D Lead Implant", Presented at Heart Rhythm Society, Denver, CO, (May 2007) 1 pg. cited by other .
Markowitz, Toby, et al., Abstract Submission, "Unleaded: The Fluoroless 3D Lead Implant", Mar. 2007 2 pgs. cited by other .
Milstein, S. et al., "Initial Clinical Results of Non-Fluoroscopic Pacemaker Lead Implantation." (pre-presentation abstract) May 14-17, 2008. 2 pgs. cited by other .
Milstein, S. et al., "Initial Clinical Results of Non-Fluoroscopic Pacemaker Lead Implantation." (poster presentation) May 14-17, 2008. 1 pg. cited by other .
Nelder, J.A., et al. "A simplex method for function minimization." vol. 7, Issue 4, (1965) pp. 308-313.The Computer Journal. cited by other .
Savage, George, M.D., "Electric Tomography (ET)--A Novel Method for Assessing Myocardial Motion and Cardiac Performance", Heart Rhythm Society, Denver, CO (May 9-12, 2007) 1 pg. cited by other .
Wittkampf, Fred, H.M., et al., "LocaLisa: New Technique for Real-Time 3-Dimensional Localization of Regular Intracardiac Electrodes." Circulation Journal of the American Heart Association, 1999; 99; 13-12-1317. cited by other .
Wittkampf, Fred., H.M., et al. "Accuracy of the LocaLisa System in Catheter Ablation Procedures." Journal of Electrocardiology vol. 32 Supplement (1999). Heart Lung Institute, University Hospital Utrecht, The Netherlands. cited by other .
1. A system to determine a location of an electrode within a volume, comprising: a medical device sized and shaped to be positioned by implantation and contained within the volume, the medical device including: a lead having a first implantable electrode; an implantable case containing an electronics system operable to receive a signal from the first implantable electrode, wherein the first implantable electrode is operable to move based on contact with a surface within the volume and relative to the implantable medical device; a connector extending from the lead to be connected to the electronics system; and a current injecting system operable to inject a current into the volume between a first injecting electrode and a second injecting electrode; wherein the first implantable electrode is operable to sense a voltage at a location due at least in part to the current injected into the volume.
2. The system of claim 1, wherein the current injecting system includes: a generator positioned exterior to the volume; wherein the generator is operable to deliver the current into the volume with the first injecting electrode and the second injecting electrode; wherein the first implantable electrode of the lead is operable to sense a voltage within the volume.
3. The system of claim 2, further comprising: a third injecting electrode, a fourth injecting electrode, a fifth injecting electrode, and a sixth injecting electrode; wherein two of each of the first, second, third, fourth, fifth and sixth injecting electrodes are paired to define three axes in the volume; wherein the generator is operable to determine a period for injecting a current into the volume between each of the pairs of the injecting electrodes.
4. The system of claim 3, wherein the injected current has a frequency of about 1 kHz to about 10 kHz; wherein the generator is operable to inject a current between the respective pairs of the injecting electrodes for about 10 cycles to about 200 cycles; wherein after the selected number of cycles a current is injected with a different pair of the injecting electrodes from the previous pair of injecting electrodes.
5. The system of claim 3, further comprising: a null period where no current is injected by the generator; wherein the null period is operable to synchronize the current injecting system and the implantable medical device.
6. The system of claim 1, wherein the current injecting system includes: a current source contained with the implantable medical device; a second implantable electrode and a third implantable electrode; wherein the third implantable electrode is a case of the implantable medical device; wherein the current source is operable to inject a current using the first injecting electrode and the second injecting electrode selected from at least two of the first implantable electrode, the second implantable electrode, and the third implantable electrode; wherein at least one of the first implantable electrode, the second implantable electrode, and the third implantable electrode is operable to sense a voltage due at least in part to the injected current.
9. The system of claim 2, wherein the implantable medical device further includes an internal telemetry system; wherein the internal telemetry system is operable to synchronize the signal received from the electrode and the current generated into the volume with the generator.
10. The system of claim 1, wherein the implantable medical device further includes: a pacing and sensing module having an amplifier module through which a signal is transmitted and amplified from the first implantable electrode.
11. The system of claim 10, wherein the signal from the amplifier module is transmitted to at least an impedance/position signal detection system and one of an electrogram filter, a myocardial infarction detection system, a sensing system for timing and rhythm detection, and an evoked response detection system.
12. The system of claim 10, wherein the implantable medical device further includes: a filter having a band pass range of at least the injected current frequency.
16. The system of claim 14, wherein the processor is further operable to transform the undersampled signal in a selected frequency domain to identify three signal components; wherein the signals are measured over time to determined information regarding the position of the electrodes.
18. A system to measure a position of a surface of a portion of an anatomy, comprising: a medical device sized to be implanted with the anatomy, including: a lead including a first electrode fixed to a surface of the anatomy; a position sensing system operable to sense a voltage at the first electrode at least a first time and a second time to generate a first sensed voltage signal and a second sensed voltage signal with the first electrode; and a processor operable to compare a first sensed voltage and a second sensed voltage at the first electrode; and a current injecting system operable to inject a current into the anatomical system to generate the voltage sensed by the first electrode; wherein the processor undersamples the first sensed voltage signal and the second sensed voltage signal from the position sensing system with intentional aliasing.
20. The system of claim 19, further comprising: a telemetry system wherein the undersampled signal is operable to transmitted from the medical device that includes substantially necessary information regarding a position of the first electrode at a selected current drain from the finite power supply.
21. The system of claim 20, further comprising: a processor system having a second processor positioned exterior to the anatomy; wherein the second processor is operable to transform the undersampled signal in a selected frequency domain to identify three signal components; wherein the signals are measured over time to determine information regarding a position of the first electrode.
22. The system of claim 19, wherein the processor is operable to transform the undersampled signal in a selected frequency domain to identify three signal components; wherein the signals are measured over time to determined information regarding the position of the electrodes.
24. The system of claim 19, wherein the current injecting system is included in the medical device and the injected current is powered by the power source; wherein the implantable medical device further includes: a second electrode and a third electrode; wherein the current injecting system is operable to use the power source as a current source system to inject a current between at least the first electrode and the second electrode; wherein the position sensing system is operable to sense a voltage with at least the third electrode.
25. The system of claim 24, wherein at least the first electrode is implanted within a surface of a heart in the anatomical system; wherein the first sensed voltage signal and the second sensed voltage signal is operable by the processor to determine a position of at least the surface of a wall of the heart at least two times; wherein the processor is operable to execute instructions to determine a change in position of the surface of the wall of the heart between the first time and the second time.
27. A system to determine a location of an electrode with a volume, comprising: a medical device sized to be positioned and contained within the volume, including: an implantable case; a lead connected to a connector associated with the implantable case having a first implantable electrode, wherein the first implantable electrode is operable to contact and move with a surface within the volume; and a processor positioned within the implantable case and operable to execute a first set of instructions when a signal from the lead is received to affect the volume in a first manner; and a current injecting system operable to inject a current into the volume between a first injecting electrode and a second injecting electrode and the first implantable electrode is operable to sense a voltage at a location due at least in part to the injected current; wherein the processor is operable to change the first set of instructions based upon the sensed voltage to affect the volume in a second manner different from the first manner.
28. The system of claim 27, wherein the current injecting system includes three pairs of injecting electrodes that are operable to define three substantially orthogonal axes of current within the volume; wherein the processor is operable to undersample a signal based the sensed voltage to produce an undersampled signal; and wherein the implantable medical device further includes a telemetry system operable to transmit the undersampled signal that relates to the voltage sensed at the location.
29. The system of claim 28, wherein the processor is operable to execute instructions to determine a position of the first implantable electrode based at least in part on the voltage sensed at the location; wherein the determined position can be transmitted from the implantable medical device.
30. The system of claim 29, further comprising: an external processor system; wherein the external processor system is operable to receive the transmitted determined position; wherein the external processor system is operable to determine a condition of an anatomical feature within the volume based upon the transmitted determined position.
31. The system of claim 30, further comprising: a second implantable electrode; wherein the first implantable electrode is operable to sense a voltage at a first location and a second implantable electrode is operable to sense a voltage at a second location; wherein at least one of the processor or the external processor system is operable to determine a dimension between the first implantable electrode and the second implantable electrode at the respective locations.
33. A method of measuring movement of an electrode within a volume, comprising: providing an implantable device; implanting a lead extending from the implantable device into a surface within the volume, the lead having a first electrode; injecting a current in the volume; sensing a voltage in the volume with the first electrode; sending a sensed voltage signal based on the sensed voltage to an electronics system of the implantable device; and undersampling the sent sensed voltage signal.
34. The method of claim 33, wherein sensing a voltage includes: sensing a first voltage at a first time and sensing a second voltage at a second time; determining a first position of the first electrode with the first sensed voltage; and determining a second position of the first electrode with the second sensed voltage.
35. The method of claim 34, further comprising: implanting the first electrode in a surface; determining a first position of the surface with the determined first position of the first electrode; and determining a second position of the surface with the determined second position of the first electrode.
36. The method of claim 34, further comprising: providing a processor in the implantable device; providing a pacing system operable to deliver a pacing signal based upon first instructions executed by the processor; and executing second instructions with the processor based upon the determined first position and the determined second position to alter the pacing signal.
37. The method of claim 34, further comprising: placing a second electrode; determining a third position of the second electrode; and determining a distance between at least one of the determined first position and the determined second position and the determined third position.
38. The method of claim 37, further comprising: implanting a second lead having the second electrode.
40. The method of claim 34, further comprising: transmitting the undersampled signal that includes substantially necessary information at a selected current drain on a finite power supply to an external processor system; and determining an anatomical definition based upon the transmitted undersampled signal.
41. The method of claim 33, further comprising: generating the current to be injected into the volume with a generator that is external to the volume; and synchronizing the external generation of the current from the generator with the sensing of the voltage with the first electrode.
43. A system to measure a position of a surface of a portion of an anatomy, comprising: an implantable medical device including: a lead including a first electrode; a position sensing system operable to sense a voltage at the first electrode, the position sensing includes at least one of an electrogram filter, a myocardial infarction detection system, a sensing system for timing and rhythm detection, and an evoked response detection system; a first processor operable to compare a first sensed voltage and a second sensed voltage at the first electrode; a power source having a finite power supply; and a first telemetry system operable to transmit and receive information regarding at least the first electrode; and a current injecting system operable to inject a current into the anatomy to generate the voltage sensed by the first electrode, including: a first pair of injecting electrodes and a second pair of injecting electrodes; a current source system operable to inject a current between the first pair of injecting electrodes and the second pair of injecting electrodes; and a second telemetry system operable to communicate with the first telemetry system; wherein the first processor undersamples a signal from the first electrode to include intentional aliasing, wherein the undersampled signal is operable to be transmitted with the first telemetry system from the implantable medical device to the second telemetry system of the current injecting system, wherein the undersampled signal includes substantially all necessary information and is transmitted at a selected current drain from the finite power supply; wherein a second processor of the current injecting system is operable to transform the undersampled signal in a selected frequency domain to identify three signal components; wherein the signals are measured over time to determine information regarding the position of the first electrode.
44. The system of claim 43, wherein the implantable medical device further includes: a second electrode; wherein a voltage at the first electrode is compared to a voltage sensed at the second electrode; wherein the processor is operable to execute instructions to determine a relative position of the first electrode and the second electrode, to identify a dimension of the anatomy.
Interconnected with the lead connector block 24 can be a first lead 28a, a second lead 28b, a third lead 28c and a fourth lead 28d. Each of the leads 28a-28d can include respective lead block connection portions 30a-30d. Each of the leads can also include a respective sheath or insulation portion 32a-32d and respective lead tips or tip electrodes 34a-34d. It will be understood that each of the leads 28a-28d can also include multiple electrodes, such as optional ring electrodes 36a-36d. Accordingly, it will be understood that each of the leads 28a-28d can include one or more electrodes, for various purposes, such as sensing, defibrillation, pacing, or other appropriate purposes. Various leads such as the lead 28d, can also include multiple ring electrodes 36d'-36d''' for use in gathering information regarding the heart, as further discussed herein.
The IMD 20 can be positioned within a patient 40 as illustrated in FIG. 2. The IMD 20 can be positioned in any appropriate portion of the anatomy of the patient 40, such as generally in a thoracic cavity, a shoulder area, or other appropriate portion of the patient 40. The leads 28a-28d can be positioned within a heart 42 of the patient 40 in any appropriate manner, such as by guiding the leads 28a-28d through the superior vena cava 44. The leads 28a-28d can be attached or fixed to a wall of the heart 42. For example, tip electrodes 34a-34d can include a helix that is screwed into a wall of the heart 42. It will be understood, that the leads 28a-28d or any appropriate lead can be implanted in any appropriate portion of the patient 40, such as in or near the liver, spleen, diaphragm, etc.
The leads can be positioned in any appropriate portion of the anatomy, such as positioning the first lead 28a in a right atrium 46, positioning the second lead 28b in the right ventricle 48, and positioning the third lead 28c in the left ventricle 50. It will be understood that the leads can be implanted at any appropriate location within the heart 42, such as near the tricuspid valve 42a, near a ventricle apex 42b, or any other appropriate specific location. The electrodes 36d'-36d''' of the lead 28d can be provided solely for gathering and sensing position information. Accordingly, those may be located against a wall of the heart 42. Pacing and defibrillation leads 28a-28c can be positioned generally within at least three regions of the heart 42 for pacing the heart 42, for providing defibrillation into the heart 42, or other appropriate purposes.
Current can be passed through the patient with the bioimpedance system 80. The bioimpedance system 80 can include a controller and a generating module 81 that drives three pairs of patch electrodes. The patch electrodes can be provided in pairs to form three orthogonal axes, such as an X-axis, a Y-axis and a Z-axis. For example, a first pair of patch electrodes 82a, 82b can inject a current through the patient 40 to form the X-axis. A second pair of patch electrodes 84a and 84b can be positioned on the patient 40 to inject a current form a Y-axis. Finally, two patch electrodes 86a and 86b can be positioned on the patient 40 to inject a current along the Z-axis.
The patch electrodes 82a-86b can be used to inject a current through the patient 40 in any appropriate manner. For example, the patch electrodes used to inject a current can be similar to those disclosed in U.S. Pat. No. 5,697,377, issued on Dec. 16, 1997. Another appropriate system for injecting current is similar to the Localisa.TM. intracardiac navigation system, sold by Medtronic, Inc. having a place of business in Minneapolis, Minn. It will be understood that the bioimpedance system (EP system) 80 can include various portions that are different from the specifics discussed above, but can generally inject a current within the patient 40 in a similar manner.
Generally, a current of a selected frequency is delivered within the patient 40 through patches 82a-86b. As the current passes through the tissue, a voltage drop occurs as a result of the impedance of the tissue. This voltage can be measured along the corresponding X, Y, and Z axes. For example, muscle tissue, fluid filled organs (such as blood vessels or veins or the heart) are sufficiently conductive to allow for a voltage drop across different areas that can be measured with the electrodes of the leads 28a-28d or even the electrode of the case 22. These voltages can be related to the position of the electrodes based upon knowing the delivered currents. In addition, relative positions of the electrodes can be determined based upon a change in sensed voltage over time.
The patch electrodes 82a-86b can be positioned on the patient 40 using any appropriate mechanism, such as appropriate or tolerated adhesives, or other appropriate means. The patches are generally placed in conductive contact with the skin of the patient 40 to allow for delivery of the current through the internal organs and tissue of the patient 40. The current can generally be about 0.01 mA to about 2.00 mA, including about 1.0 mA. The current is generally injected as an alternating current at about 30 kHz, including about 5 kHz to about 50 kHz.
As discussed above, the IMD 20 and the respective leads 28a-28d are generally positioned within the patient 40. The injection of the current between the patches 82a-86b can generate a voltage that can be measured by the electrodes 34a-36c of the IMD 20 without further invasive procedures. That is, the IMD 20 and leads 28a-28d are already within the patient 40 and no additional internal electrodes are necessary to be introduced into the patient such as by the use of a catheter, etc. As discussed further herein, the measurements of the voltage(s) within the patient 40 can be used to determine positions of the various electrodes that are within the patient 40. The determined position of the electrodes can be used to determine conditions and measurements of the patient 40, such as cardiac dimensions or positions.
With reference to FIG. 3, the electronics system 26 of the IMD 20 is illustrated. The electronics system 26 can be positioned within the IMD 20 in any appropriate manner and is diagrammatically illustrated. The electronics system 26 of the IMD 20, can include a battery or other power storage device 100 to power the electronics system 26. The battery 100 can transmit power to a processor and memory (P&M) module 102 of the electronics system 26. The processor can be any appropriate processor, such as a processor operable to process signals received from the leads 28a-28d and send instructions, such as signals, to the leads 28a-28d. In addition, the P&M module 102 can include a memory module, either integrated with or in communication with the processor, to store sensed signals from the leads 28a-28d, processed data and programming information from the external programmer 60, discussed above.
The P&M module 102 can be interconnected or in communication with a pacing and sensing signal processing (PSS) module 104. It will be understood that more than one PSS module 104, such as PSS modules 104a-104d, can be provided with the IMD 20, such as a distinct PSS module for each of the leads 28a-28d. Each PSS module 104 can receive and send information to and from the P&M module 102 as well as from leads 28a-28d. Further, each of the PSS modules can include the modules and/or circuitry discussed further herein relative to the exemplary PSS module 104. The information from P&M module 102 can direct the PSS module 104 to output a pacing stimulus to a connected lead, 28a-28d. The occurrence of sensing can be communicated to P&M module 102 from PSS module 104. The battery can power the PSS module 104. The PSS module 104 is in communication with the leads 28a-28d that are attached to various portions of the patient 40.
The P&M module 102 can control timing, detection, sensing, pacing, telemetry, and other functions. Generally, the P&M module 102 can perform functions necessary for pacing functions, diagnostic functions and for follow-up information that is telemetrically transmitted. As is understood, the IMD 20 can be provided for pacing of the heart 42 of the patient 40 in any appropriate and programmed manner. The P&M module 102 can send a signal to the PSS module 104, which can, in turn, send a pacing signal through each of the leads 28a-28c and sense signals from each of the leads 28a-28d.
With additional reference to FIG. 4 and continuing reference to FIG. 3, a detailed view of the PSS module 104 is illustrated. Each of the leads, such as the lead 28a, communicates with the PSS module 104. Each of the leads can be connected to a separate PSS module 104, or a multiplex switch, as discussed herein can be used to allow communication between each of the leads 28a-28d and the single PSS module 104. The PSS module 104 can include various distinct and selected portions, such as those illustrated in FIG. 4. The various components discussed in detail here are exemplary and can be selected according to various embodiments.
Initially, as discussed above, each of the leads can be in communication with a pace module such as module 110. The pace module 110 can combine and transmit a selected pacing stimulus pulse as well as current, of select frequencies to the electrode 28a, based upon instructions or commands from the P&M module 102 and power from the battery 100. Providing a pacing stimulus pulse through the lead 28a is generally known and will not be discussed in detail here.
The pacing and sensing signal processing module exemplified by module 104 can include signal filters for processing information in various spectral portions to isolate electrograms, the electrical signal from electrodes in or on the heart that reflect electrical activation, for example, from lead 28a. The electrogram information can be sent through the telemetry module 106 and antenna 108 to the external programmer 60 for display and/or assisting in augmenting or programming the IMD 20. The electrogram signals can be used to assist in programming the IMD 20.
Detection of electrode movement can be accomplished by circuitry within module 122. By injecting a current through lead 28a, from current source 130, an electric field can be established within cardiac tissue or other tissue of interest. Detection and analysis of the resultant sensed voltage due to the injected current can be used to measure and establish movement of cardiac tissue. Analyzing the signals that relate to the frequency of the injected current allows for the determination of the heart's motion 42. If, for example, the injected current is about 30 kHz, then a band pass range of about 25 to about 35 kHz in circuit module 122 could be used to assist in detecting a signal from the lead 28a and determining motion. Analysis of the signal to determine motion can be used by a P&M module 102 to both provide for cardiac pacing and/or defibrillation of the heart for the patient 40. Motion may be used to determine whether an alteration in pacing or defibrillation is required.
With further reference to FIG. 4, a current source module 130 can be optionally provided as a part of the PSS module 104. The current source module 130 can be used to direct a current through any appropriate electrodes of the IMD 20, including those of the leads 28a-28d or the case 22. The current source 130 can deliver a current through the patient 40 when the external bioimpedance system 80 is not present. Electrodes of leads 28a-28d can be used to measure voltage changes over time to determine relative motion of selected portions of the heart 42, or any appropriate portion. For example, a voltage can be measured in the right ventricle for determination of right ventricular stroke volume or other measurements over time by sensing the voltage over time.
Once the IMD 20 including the various electrodes 28a-28d, or any appropriate number of leads is implanted in the patient 40, selected electrodes can be used to determine positions of other selected electrodes. For example, the patch electrodes 82a-86b can be used to inject current that can be sensed with the electrodes of the IMD 20. According to various embodiments, two of the electrodes of the IMD 20 can also or alternatively be used to inject a current from the current source 130 into the patient 40 to generate a voltage to be sensed by another of the electrodes of the IMD 20. For example, the distal electrode 34b of the lead 28b can be a first electrode and the case 22 can be a second electrode.
The case electrode 22 and the distal tip electrode 34b can be used to inject a current through the tissue of the patient 40. Any of the electrodes between the case electrode 22 and the distal tip electrode 34b can be used to measure a voltage. Accordingly, a current injected from the current source 130 and transmitted through the case electrode 22 and the distal tip electrode 34b and can be used to generate a voltage at any of the electrodes between the case electrode 22 and the distal tip electrode 34b. These voltages can be measured and transmitted through the position sensing module 122 for processing by the P&M module 102 and transmission with the telemetry module 106 or for saving in the P&M module 102.
By injecting the current with an implanted electrode within the patient 40, error produced by positioning an electrode patch, such that the patches 82a-86b, on a surface of the patient's 40 skin can be reduced or eliminated. In addition, by using the electrodes implanted as a part of the IMD 20, the IMD 20 can provide a current injection at any time without the need of external or additionally applied current patches of the bioimpedance system 80. For example, the IMD 20 can be programmed to determine a location of a selected electrode 5 times over a selected period. The IMD 20 can, therefore, provide the injected current and measure a voltage at the selected electrode without additional instruments. Accordingly, the electrodes of the IMD 20 can be used to provide substantially efficient measurements of the positions of electrodes implanted as a part of the IMD 20, which correlate to various anatomical features or conditions. As discussed here, the positions of the electrodes of the leads 28a-28d can be measured to determine stroke volume, ejection fraction, dimensions of selected chambers of the heart, and various other hemodynamic indices for the RV, LV, and a combination of RV and LV dimensions. In addition, when electrodes are positioned in appropriate locations, such as on opposite sides of a heart wall, a heart wall thickness or change in thickness can also be measured.
The positions of the electrodes are determined based upon the measured voltages, such as in the Localisa.TM. intracardiac navigation system sold by Medtronic, Inc. The electrodes of the IMD 20, however, are not directly connected to the external bioimpedance system 80. Because the leads and electrodes positioned within the patient 40 are not directly connected to the bioimpedance system 80, a determination of which axis, X, Y, or Z, current is being injected must be provided. According to various embodiments, a time division multiplex system can be provided to allow for injection of each of the different axes at a substantially different time.
In a time division multiplex system, a current at each of the axes can be injected at a different time within the patient 40 as illustrated in FIG. 5. As illustrated in FIG. 2, the patches 82a-86b can be positioned on the patient 40. During a first time, the patches 82a and 82b can be energized to inject a current within the patient 40. At a second time, the patches 84a and 84b can be energized, and at a third time, the patches 86a and 86b can be powered to deliver the current along the respective axes.
According to one example, the generator 81 is operable to inject a current at an appropriate frequency into the patient 40 through the patch electrodes 82a-86b. The wave of the generator 81 can include any appropriate frequency and can be selected for various purposes, such as a sampling rate, a power drain, and other appropriate purposes. The generator 81 can also include a switch to allow for switching between selected pairs of the patch electrodes 82a-86b over any period of time, including any appropriate number of cycles.
According to various embodiments, the generator 81 can generate a frequency of about 30 kHz and can switch between each of the patch electrode pairs at any appropriate time interval, such as interval T160, illustrated in FIG. 5. As illustrated in FIG. 5, time is illustrated on an x-axis 162. Substantially parallel to the time axis 162 are lines illustrating the X-axis patch electrodes 164, the Y-axis patch electrodes 166, and the Z-axis patch electrodes 168. An active current pulse 170 illustrates that current is directed to the respective patches at a sequential time period T. In addition, a rest or null period 172 is provided between each series of injecting current along the X, Y and Z axes through the patch electrodes 82a-86b.
In addition, the sequencing as illustrated in FIG. 6, allows for synchronization between the generator 81 and the position sensing module 122. For example, the position sensing module 122 can be programmed or hard-wired regarding the sequence of the powering of the axes of the patch electrodes 82a-86b. That is, the position sensing module 122 can know that the patches sequentially energize the X, Y, and Z axes. The null period 172 can be easily detected as a starting point so that the position sensing module 122 can determine the sequencing of the axes energizing. That is, after the null period 172, the next signal sensed is known to be the X-axis. Accordingly, the null time 172 can be an efficient and low power mechanism to synchronize the position sensing module 122 and the generator 81.
In an attempt to reduce the bandwidth required to transmit the signal of the sensed voltage, the signal can be undersampled at, for example, 100 Hz. As illustrated in FIG. 6B, an undersampled signal is far less dense than the complete signal illustrated in FIG. 6A. Due to aliasing, however, the original signal can not be fully recovered to determine the voltage sensed with the electrodes of the leads 28a-28d to allow for the determination of a position of the electrodes, as discussed above.
The sensed voltage can be used to determine positions of the various electrodes of the leads 28a-28d. The voltages can be sensed substantially continuously when a current is injected. The positions of the electrodes can be determined using the external bioimpedance system 80 or an internal bioimpedance system comprising at least two electrodes of the IMD 20. Injecting a current between any two electrodes for measurements of a voltage at another electrode can be used to determine a position of the electrode.
The electrodes of the leads 28a-28c can be positioned for pacing, defibrillation, sensing, and other appropriate purposes. Although any of the leads can be used for determining position information, it will be understood that the leads 28a-28d can include any appropriate number of electrodes to be used substantially only for position determination. For example, the lead 28d can include a tip electrode 34d and any appropriate number of intermediate electrode rings, such as three intermediate electrodes 36d', 36d'', and 36d'''. The lead 28d can be positioned along or attached to a wall of the heart 42 to provide plural points for position information. These multiple points can provide a substantially detailed view of a particular portion of the heart 42, such as a wall of the heart, when used to sense a position of the multiple electrodes 36d'-36d''' and 34d. It will be further understood that the multiple lead electrodes can be positioned at any appropriate distance along the lead 28d and can even be passed through more than one chamber of the heart 42 to illustrate relative motion of different portions of the heart 42.
When using the electrodes of the leads 28a-28d, it can be selected to calibrate the position information or the voltages generated relative to the electrodes of the IMD 20. The calibration can include determining the position between any two electrodes having a known position. For example, on the lead 28a, the tip 34a is generally at a fixed position relative to the ring electrode 36a. Accordingly, a determination of a position of each of the two electrodes 34a, 36a and this can be used to calibrate the position system. In addition, it will be understood that when the patch electrodes 82a-86d are positioned on the patient 40, the patch electrodes can be of appropriate sizes to inject the appropriate currents in the patient 40. In addition, the patch electrodes can be sized to provide an increase in a signal-to-noise ratio and decrease distortion generated by injecting a current into the patient 40.
The electrodes of the leads 28a-28d can be used to measure the positions of electrodes associated with each of the leads. The information can be transmitted, either as specific position information or as raw voltage data, to the external programmer 60 or the external bioimpedance system 80 for processing of position information. When the various leads are positioned in the right atrium, right ventricle, and the left ventricle, the leads can generally include electrodes that are substantially fixedly implanted into heart wall tissue in the various chambers. This also positions multiple electrodes within the various chambers so that multiple positions, regarding the various chambers, can be determined using the leads 28a-28d. The information relating to the positions of the leads 28a-28d can be used to identify various anatomical information, such as diseased regions of the heart, stroke volume, volume change and information relating to the various chambers of the heart 42, and other appropriate information. Various examples of information that can be determined using positions of various anatomical features is discussed in U.S. Patent Application Publication No. 2008/0132800 published on Jun. 5, 2008, incorporated herein by reference.
Previous Patent US 7,941,212 | Next Patent US 7,941,214